Clarient Diagnostic Services, Inc. is a leading provider of comprehensive, cancer-diagnostic laboratory services. With our advanced technologies, we are able to provide pathologists and oncologists with more accurate and detailed information enabling better characterization and assessment of cancer, which can result in a more accurate diagnosis and more effective treatment. In addition, Clarient’s pharma services are partnering with pharmaceutical companies to reduce cost while accelerating the oncology drug and companion diagnostic development that can result in better outcomes for patients.
From its state-of-the-art diagnostic laboratory to its Internet-based PATHSiTE® portal, we provide advanced oncology diagnostic services to pathologists, oncologists, hospitals and biopharmaceutical companies. We are also identifying “companion” diagnostic markers for therapeutics in leukemia/lymphoma, as well as breast, prostate, lung and colon cancers.
Clarient is improving the lives of those affected by cancer by bringing clarity to a complex disease.